Workflow
伟思医疗(688580):2024年报点评:夯实康复基石业务,布局医美能量源市场

Investment Rating - The report maintains an "Outperform" rating for the company with a target price of RMB 57.68, indicating a potential upside from the current price of RMB 49.90 [1][8]. Core Insights - The company is solidifying its rehabilitation core business while expanding into the emerging medical aesthetics energy source market. The report highlights the company's strategic upgrades in technology platforms and product lines, which are expected to drive future growth [1][8]. - Despite a weak consumption recovery, the forecasted EPS for 2025-2026 is RMB 1.28 and RMB 1.51, with an additional forecast of RMB 1.81 for 2027. The company is positioned in emerging sectors like medical aesthetics and rehabilitation robotics, suggesting potential for a second growth phase [1][8]. Financial Summary - Revenue for 2024 is projected at RMB 400 million, a decrease of 13.45% from the previous year. The net profit attributable to shareholders is expected to be RMB 102 million, down 25.16% [4][8]. - By product line for 2024: electrical stimulation revenue is RMB 37 million (-41.75%), magnetic stimulation is RMB 172 million (-13.92%), electrophysiology is RMB 65 million (+0.25%), consumables and accessories are RMB 79 million (+4.14%), and laser radiofrequency is RMB 30 million (-20.87%) [4][8]. - The company is focusing on core product upgrades and expansion in rehabilitation, with significant developments in electrical stimulation and magnetic stimulation products expected to be certified in 2024 [4][8]. Emerging Market Strategy - The company is increasing investments in emerging fields, particularly in the medical aesthetics energy source market. It has developed products such as shaping magnets, picosecond lasers, and radiofrequency devices, targeting gynecology, dermatology, and medical aesthetics [4][8]. - Sales breakthroughs are anticipated in maternal and child channels and light medical aesthetics markets for 2024, with the Nd:YAG frequency-doubled picosecond laser already certified [4][8].